Xbrane Biopharma AB (publ) announced the Nomination Committee for the AGM in 2024 consists of Saeid Esmaeilzadeh, appointed by Systematic Group AB, the Company's larger shareholder, Bengt Göran Westman, the Company's second larger shareholder, Oscar Bergman appointed by Swedbank Robur Fonder, the Company's third larger shareholder, Anders Tullgren, Chairman of the Company co-opted member. In addition, Saeid Esmaeilzadeh, has been appointed Chairman of the Nomination Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2295 SEK | +20.54% | +13.61% | -97.70% |
05-10 | Xbrane Biopharma, Stada Sign US Licensing Deal for Lucentis Biosimilar | MT |
05-02 | Xbrane Biopharma AB Appoints Kristoffer Bissessar Was Elected as New Director | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.70% | 32.39M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- XBRANE Stock
- News Xbrane Biopharma AB
- Xbrane Biopharma AB Announces Appointment of Nomination Committee